FASN and metabolic dysfunction-associated steatohepatitis: Moreover, the transcriptional program of lipogenesis was downregulated by NAG-Drp1si treatment in mice with NASH, as shown by the decrease in Dgat2 and Fasn mRNA levels (Figure 4D).